A spreadsheet program for modeling quantitative structure-pharmacokinetic relationships for inhaled volatile organics in humans

被引:14
作者
Béliveau, M [1 ]
Krishnan, K [1 ]
机构
[1] Univ Montreal, TOXHUM, Grp Rech Toxicol Humaine, Montreal, PQ H3C 3J7, Canada
关键词
QSAR; PBPK models; pharmacokinetics; structure; internal dose; VOCs;
D O I
10.1080/10629360412331319880
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The extent and profile of target tissue exposure to toxicants depend upon the pharmacokinetic processes, namely, absorption, distribution, metabolism and excretion. The present study developed a spreadsheet program to simulate the pharmacokinetics of inhaled volatile organic chemicals (VOCs) in humans based on information from molecular structure. The approach involved the construction of a human physiologically- based pharmacokinetic (PBPK) model, and the estimation of its parameters based on quantitative structure-property relationships (QSPRs) in an Excel (R) spreadsheet. The compartments of the PBPK model consisted of liver, adipose tissue, poorly perfused tissues and richly perfused tissues connected by circulating blood. The parameters required were: human physiological parameters such as cardiac output, breathing rate, tissue volumes and tissue blood flow rates ( obtained from the biomedical literature), tissue/air partition coefficients ( obtained using QSPRs developed with rat data), blood/air partition coefficients (Pb) and hepatic clearance ( CL). Using literature data on human Pb and CL for several VOCs ( alkanes, alkenes, haloalkanes and aromatic hydrocarbons), multi-linear additive QSPR models were developed. The numerical contributions to human Pb and CL were obtained for eleven structural fragments (CH3, CH2, CH, C, C=C, H, Cl, Br, F, benzene ring, and H in the benzene ring structure). Using these data as input, the PBPK model written in an Excel (R) spreadsheet simulated the inhalation pharmacokinetics of ethylbenzene ( 33 ppm, 7 h) and dichloromethane ( 100 ppm, 6 h) in humans exposed to these chemicals. The QSPRs developed in this study should be useful for predicting the inhalation pharmacokinetics of VOCs in humans, prior to testing and experimentation.
引用
收藏
页码:63 / 77
页数:15
相关论文
共 22 条
[1]   PHARMACOKINETIC MODELING OF TRICHLOROETHYLENE AND TRICHLOROACETIC-ACID IN HUMANS [J].
ALLEN, BC ;
FISHER, JW .
RISK ANALYSIS, 1993, 13 (01) :71-86
[2]   PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING WITH DICHLOROMETHANE, ITS METABOLITE, CARBON-MONOXIDE, AND BLOOD CARBOXYHEMOGLOBIN IN RATS AND HUMANS [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
MACNAUGHTON, MG ;
REITZ, RH ;
NOLAN, RJ ;
MCKENNA, MJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 108 (01) :14-27
[3]   PHYSIOLOGICALLY BASED PHARMACOKINETICS AND THE RISK ASSESSMENT PROCESS FOR METHYLENE-CHLORIDE [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
SMITH, FA ;
REITZ, RH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 87 (02) :185-205
[4]   Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats [J].
Béliveau, M ;
Tardif, R ;
Krishnan, K .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 189 (03) :221-232
[5]  
Beliveau M, 2003, ALTERNATIVE TOXICOLO, P479
[6]   PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING WITH TRICHLOROETHYLENE AND ITS METABOLITE, TRICHLOROACETIC-ACID, IN THE RAT AND MOUSE [J].
FISHER, JW ;
GARGAS, ML ;
ALLEN, BC ;
ANDERSEN, ME .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 109 (02) :183-195
[7]   PARTITION-COEFFICIENTS OF LOW-MOLECULAR-WEIGHT VOLATILE CHEMICALS IN VARIOUS LIQUIDS AND TISSUES [J].
GARGAS, ML ;
BURGESS, RJ ;
VOISARD, DE ;
CASON, GH ;
ANDERSEN, ME .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 98 (01) :87-99
[8]   MODELING THE TISSUE SOLUBILITIES AND METABOLIC-RATE CONSTANT (VMAX) OF HALOGENATED METHANES, ETHANES, AND ETHYLENES [J].
GARGAS, ML ;
SEYBOLD, PG ;
ANDERSEN, ME .
TOXICOLOGY LETTERS, 1988, 43 (1-3) :235-256
[9]   Validation of a physiological modeling framework for simulating the toxicokinetics of chemicals in mixtures [J].
Haddad, S ;
Charest-Tardif, G ;
Tardif, R ;
Krishnan, K .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2000, 167 (03) :199-209
[10]   A methodology for solving physiologically based pharmacokinetic models without the use of simulation softwares [J].
Haddad, S ;
Pelekis, M ;
Krishnan, K .
TOXICOLOGY LETTERS, 1996, 85 (02) :113-126